These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35264117)

  • 21. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
    Shida D; Tanabe T; Boku N; Takashima A; Yoshida T; Tsukamoto S; Kanemitsu Y
    Ann Surg Oncol; 2019 May; 26(5):1358-1365. PubMed ID: 30719633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage Ⅳ Colorectal Cancer? Results From SEER Database Analysis.
    Yi C; Li J; Tang F; Ning Z; Tian H; Xiao L; Wang A; Zong Z
    Am Surg; 2020 May; 86(5):499-507. PubMed ID: 32684032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Better survival in right-sided versus left-sided stage I - III colon cancer patients.
    Warschkow R; Sulz MC; Marti L; Tarantino I; Schmied BM; Cerny T; Güller U
    BMC Cancer; 2016 Jul; 16():554. PubMed ID: 27464835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial.
    von Einem JC; Heinemann V; von Weikersthal LF; Vehling-Kaiser U; Stauch M; Hass HG; Decker T; Klein S; Held S; Jung A; Kirchner T; Haas M; Holch J; Michl M; Aubele P; Boeck S; Schulz C; Giessen C; Stintzing S; Modest DP
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1607-14. PubMed ID: 24816724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
    Chen D; Li L; Zhang X; Gao G; Shen L; Hu J; Yang M; Liu B; Qian X
    Medicine (Baltimore); 2018 Mar; 97(10):e0097. PubMed ID: 29517682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial.
    Tapia Rico G; Price T; Tebbutt N; Hardingham J; Lee C; Buizen L; Wilson K; Gebski V; Townsend A
    Clin Colorectal Cancer; 2019 Jun; 18(2):141-148. PubMed ID: 30713134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is metastasectomy a worthy option?-the role of surgery in metastatic colon cancer to liver and lungs.
    Lemini R; Attwood K; Almerey T; Gunn J; Yeager TE; Elias AW; Partain K; Jorgensen MS; Ji W; Gabriel EM; Colibaseanu DT
    J Gastrointest Oncol; 2019 Dec; 10(6):1032-1048. PubMed ID: 31949921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases.
    Bajrić T; Kornprat P; Faschinger F; Werkgartner G; Mischinger HJ; Wagner D
    Eur J Surg Oncol; 2022 Mar; 48(3):615-620. PubMed ID: 34620509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.
    Alawadi Z; Phatak UR; Hu CY; Bailey CE; You YN; Kao LS; Massarweh NN; Feig BW; Rodriguez-Bigas MA; Skibber JM; Chang GJ
    Cancer; 2017 Apr; 123(7):1124-1133. PubMed ID: 27479827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival benefit of primary and metastatic tumor resection for colon cancer with liver metastases: A population based, propensity score-matched study.
    Qiao Y; Qiao Y; Li H; Fu J; You S
    Front Surg; 2022; 9():959826. PubMed ID: 36111222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the surgical benefit of primary tumor resection in patients with stage IV colorectal cancer.
    Yang Y; Lam W; Lyu Z; Ouyang K; Chen R; Wang J; Wu D; Yang Z; Li Y
    Asian J Surg; 2024 Nov; 47(11):4735-4743. PubMed ID: 38609833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of chemotherapy vs resection of the primary tumour as the initial treatment in older patients with Stage IV colorectal cancer.
    Mehta HB; Vargas GM; Adhikari D; Dimou F; Riall TS
    Colorectal Dis; 2017 Jun; 19(6):O210-O218. PubMed ID: 28304120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
    Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
    Front Oncol; 2022; 12():930491. PubMed ID: 35912176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
    Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
    AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
    [No Abstract]   [Full Text] [Related]  

  • 40. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.